ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for monitor 브라질 증권 거래소, NASDAQ, NYSE, AMEX, LSE 등 주요 거래소에서의 다양한 실시간 주식 시세를 모니터링합니다.

IVVD Invivyd Inc

2.45
0.00 (0.00%)
시간외 단일가
최종 업데이트: 17:01:42
15분 지연
기업명 주식 심볼 시장 주식 타입
Invivyd Inc IVVD 나스닥 보통주
  가격 변동 가격 변동 % 주식 가격 최근 거래 시간
0.00 0.00% 2.45 17:01:42
개장가 저가 고가 종가 전일 종가
2.45
시세 정보 더보기 »

최근 뉴스

일자 시간 출처 제목
17/05/202405:11EDGAR2Form 144 - Report of proposed sale of securities
14/05/202405:01GLOBEInvivyd to Participate at the H.C. Wainwright 2nd Annual..
10/05/202405:32EDGAR2Form S-8 - Securities to be offered to employees in employee..
10/05/202405:20EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
10/05/202405:08EDGAR2Form 8-K - Current report
10/05/202405:01GLOBEInvivyd Reports First Quarter 2024 Financial Results and..
07/05/202420:38EDGAR2Form 8-K - Current report
07/05/202420:30GLOBEInvivyd to Pursue Rapid Immunobridging Pathway to Potential..
03/05/202406:13GLOBEInvivyd to Host Conference Call Discussing First Quarter..
30/04/202420:30GLOBEInvivyd Announces $20 Million to $25 Million Improvement in..
15/04/202420:30GLOBEInvivyd Receives Healthcare Common Procedure Coding System..
12/04/202420:30GLOBEInvivyd Announces CEO Transition
05/04/202405:01GLOBEInvivyd Provides PEMGARDA™ Launch Update and Announces 2024..
28/03/202420:00GLOBEInvivyd Reports Full Year 2023 Financial Results and Recent..
23/03/202404:28GLOBEInvivyd Announces Interim Exploratory Data on VYD222 from..
23/03/202404:04GLOBEInvivyd Announces FDA Authorization for Emergency Use of..
13/02/202406:01EDGAR2Form SC 13G - Statement of acquisition of beneficial..
10/02/202406:47EDGAR2Form S-3 - Registration statement under Securities Act of..
10/02/202406:01EDGAR2Form 8-K - Current report
06/02/202406:02GLOBEInvivyd to Participate at the Guggenheim Healthcare Talks..
27/01/202406:37EDGAR2Form 4 - Statement of changes in beneficial ownership of..
27/01/202406:31EDGAR2Form 3 - Initial statement of beneficial ownership of..
08/01/202421:12EDGAR2Form 8-K - Current report
03/01/202421:06EDGAR2Form 8-K - Current report
03/01/202421:00GLOBEInvivyd Submits Request for Emergency Use Authorization..
23/12/202306:53EDGAR2Form 8-K - Current report
23/12/202306:51EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
21/12/202306:55EDGAR2Form 4 - Statement of changes in beneficial ownership of..
21/12/202306:52EDGAR2Form 4 - Statement of changes in beneficial ownership of..
21/12/202306:46EDGAR2Form 4 - Statement of changes in beneficial ownership of..
21/12/202306:44EDGAR2Form 4 - Statement of changes in beneficial ownership of..
21/12/202306:41EDGAR2Form 4 - Statement of changes in beneficial ownership of..
21/12/202306:38EDGAR2Form 4 - Statement of changes in beneficial ownership of..
18/12/202321:16EDGAR2Form 8-K - Current report
18/12/202321:00GLOBEInvivyd Announces Positive Initial Results from Ongoing..
21/11/202306:21EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/11/202306:10EDGAR2Form 8-K - Current report
10/11/202306:01GLOBEInvivyd Reports Third Quarter 2023 Financial Results and..
03/11/202305:01GLOBEInvivyd to Host Conference Call Discussing Third Quarter..
01/11/202305:01GLOBEInvivyd to Participate in Upcoming Investor Conferences
11/09/202320:10EDGAR2Form 8-K - Current report
11/09/202320:00GLOBEInvivyd Announces Dosing of First Participant in CANOPY..
06/09/202320:00GLOBEInvivyd to Participate in Upcoming Investor Conferences
05/09/202320:05EDGAR2Form 8-K - Current report
05/09/202320:00GLOBEInvivyd Appoints William Duke as Chief Financial Officer
11/08/202305:17EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
11/08/202305:04EDGAR2Form 8-K - Current report
11/08/202305:01GLOBEInvivyd Reports Second Quarter 2023 Financial Results and..
04/08/202305:01GLOBEInvivyd to Host Conference Call Discussing Second Quarter..
28/07/202305:35EDGAR2Form 4 - Statement of changes in beneficial ownership of..